Название продукции:4H-Pyrimido[6,1-a]isoquinolin-4-one, 2-chloro-6,7-dihydro-9,10-dimethoxy-
IUPAC Name:2-chloro-9,10-dimethoxy-4H,6H,7H-pyrimido[4,3-a]isoquinolin-4-one
- CAS:75535-96-5
- Молекулярная формула:C14H13ClN2O3
- Чистота:95%+
- Номер в каталоге:CM629267
- Молекулярная масса:292.72
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:75535-96-5
- Молекулярная формула:C14H13ClN2O3
- Точка плавления:-
- Smiles-код:COC1=CC2=C(C=C1OC)C1=CC(Cl)=NC(=O)N1CC2
- Плотность:
- Номер в каталоге:CM629267
- Молекулярная масса:292.72
- Точка кипения:
- Номер Mdl:
- Хранение:
Column Infos
- Ensifentrine
- Verona Pharma's Ensifentrine was accepted for NDA Review by FDA for chronic obstructive pulmonary disease (COPD) maintenance treatment. COPD is used to describe chronic lung diseases, encompassing emphysema, and chronic bronchitis. Phase 3 ENHANCE trials demonstrated Ensifentrine's efficacy and safety, showing significant improvements in lung function, symptom endpoints, and reducing the rate and risk of COPD exacerbations. Ensifentrine offers a novel mechanism of action. It is a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4); it is also an activator of the cystic fibrosis transmembrane conductance regulator (CFTR).